★ Healing

GLOW Blend

Healing · 70mg × 10 vials

BPC tells damaged tissue to heal faster, TB tells cells to migrate into the damage, and GHK tells fibroblasts to rebuild collagen and elastin while copper does the structural crosslinking.

✓ 98%+ Purity ✓ Lab Tested ✓ COA on Request ✓ Discreet Shipping ✓ Direct Support
📋 Certificate of Analysis Request the third-party COA via Telegram
Quick Start
🧪
Format
Injectable (reconstituted) · 70mg × 10 vials
🎯
Who it's for
skin aging / fine lines / wrinkles
💉
How it's run
1 mg SubQ daily (≈3 IU on a U-100 at 35 mg/ml)
When you'll notice
2-4 weeks
Pricing
$350from · kit of 10
US: 2-5 day · Intl: 7-14 day
+ $40 ship · singles $20 · free over $1k per tier
70mg × 10 vials$350
Order / Consult on Telegram →
mixed - BPC-157 ~30 min plasma / GHK-Cu ~25-60 min plasma / TB-500 ~2-3 hr plasma (tissue effects all persist days)
Half-life
continuous
Cycling
2-4 weeks
First effects
healing
Class
Overview

What Is GLOW Blend?

GLOW Blend is three peptides co-formulated into a single vial: BPC-157 (Body Protection Compound, a 15-amino-acid pentadecapeptide derived from a human gastric juice protein), TB-500 (the synthetic acetate of the active region of Thymosin Beta-4), and GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper). The rationale for combining them is that the three operate on completely different but complementary repair pathways: BPC-157 drives angiogenesis and tissue repair primarily through the VEGFR2/NO axis and accelerates fibroblast migration into wounded gut/tendon/ligament, TB-500 promotes actin sequestration and cell migration into damaged tissue and is especially potent in muscle and connective tissue, and GHK-Cu is a transcription-level signal that upregulates over 4,000 human genes (per the Broad Institute Connectivity Map analysis) toward a more youthful expression profile, with the dominant effects on collagen I/III/IV synthesis, MMP/TIMP balance, and copper delivery as a cofactor for lysyl oxidase (collagen crosslinking) and superoxide dismutase (antioxidant defense). Stacked, BPC covers gut and tendon, TB covers muscle and broad connective tissue, and GHK covers skin/hair/collagen and dermal remodeling. There is no published receptor competition between the three, no shared transporter, and forty years of independent literature on each. In plain language: BPC tells damaged tissue to heal faster, TB tells cells to migrate into the damage, and GHK tells fibroblasts to rebuild collagen and elastin while copper does the structural crosslinking. One injection replaces three.

Protocols

Typical dose ranges by experience level - educational reference. Message us and we tailor it to you.

Protocol1 mg SubQ daily (≈3 IU on a U-100 at 35 mg/ml)
FrequencyDaily for 4-8 weeks
Duration4-8 week initial block, then assess. At 1 mg/day a 70 mg vial lasts ~10 weeks; a full 10-vial kit is roughly 2 years of research runway at beginner dose.

First-time peptide users should ALWAYS start at 1 mg/day. The most-reported beginner complaint is sting on injection from the copper component, which is dose-dependent. Beginners with active injury or recovery focus can run the same 1 mg dose but inject closer to the target tissue. Reconstitute slowly and swirl gently, do not shake. Skin and hair changes are slow, visible difference at 4-8 weeks not days.

Protocol2 mg SubQ daily (≈6 IU at 35 mg/ml)
FrequencyDaily, or 5 days on / 2 off for customers wanting a built-in break
Duration8-12 week continuous blocks, well-tolerated long-term. Some community protocols cycle 4-8 weeks on / 2-4 weeks off (Jordan's own framing for some customers) but continuous use is also fine and matches GHK-Cu literature.

This is the band most PP customers run GLOW at. 2 mg/day on a 70 mg vial = ~5 weeks per vial, full 10-vial kit = ~1 year of research. Most customers describe noticeable recovery improvement (less soreness between gym sessions, faster sleep recovery) within 2-3 weeks and visible skin changes by week 4-6.

Protocol2.5-4 mg SubQ daily, often split AM/PM for steady tissue exposure
FrequencyDaily, sometimes 2x/day during acute injury or active wound healing blocks
Duration8-12 week active healing blocks for injury focus, then taper back to 1-2 mg/day maintenance. Continuous low-dose maintenance is the most common long-term pattern.

Advanced users running GLOW for post-surgical recovery often pair it with microneedling-assisted topical GHK-Cu (separate 1g raw powder, compounded at 0.1-0.5% in HA base) on the same target area. KLOW (GLOW + KPV) is the natural advanced upgrade for inflammation-driven skin conditions or autoimmune-adjacent customers.

What To Expect
2-4 weeks
Skin/recovery feel
4-8 weeks
Visible skin/hair changes
Side Effects

Straight talk - what people actually report, and what the studies measured.

What users report
From forums, Discord & TikTok
  • Injection site sting/burn on push: the most-reported sensation, dose-dependent, attributed to the GHK-Cu copper component. Mitigated by larger BAC volume (3 ml vs 2 ml), warming vial before draw, slow push, injecting into fattier tissue, site rotation. Recurring in PP DMs (multiple customer reports including Lynn 2026, etc.)
  • Mild bruising at injection site: common with daily SubQ, low severity
  • Cloudy reconstitution: reported as a customer-experience flag rather than a true side effect, the GHK-Cu blue solution can appear cloudy if mixed too fast or cold-shocked, resolves on gentle swirl and warming
  • Skin tingling at injection area: occasional, transient
  • Stinging when injecting on a cold vial: pull vial from fridge 5-10 min before injecting
  • Hair regrowth "telogen rush" first 2-4 weeks of hair-focused protocols: occasional anecdotal reports, usually resolves into regrowth phase
  • Staining: the copper-blue color stains fabric if a vial leaks, not a side effect but a real customer experience flag
  • No GI effects, no appetite changes, no mood effects, no libido impact, no sexual side effects reported across the PP customer base at standard doses
What the studies show
Measured in clinical trials
  • BPC-157 in human use: no documented serious adverse events in the published human pilot data; the compound has not been through large Phase 3 trials, most safety reads come from extensive animal work and small human series
  • TB-500 in human use: largely preclinical/veterinary data; no documented serious adverse events in published human research at therapeutic doses
  • GHK-Cu: 40+ years of published research, exceptionally clean safety profile, no documented systemic toxicity at therapeutic doses, no significant treatment-related AEs above placebo in diabetic ulcer and facial wrinkle trials
  • Local injection site reactions: occasional mild redness/swelling/stinging, frequency low single digits in published GHK-Cu series, similar low signal in BPC-157 human pilots
  • Allergic reactions to any of the three components: extremely rare; copper allergy is the most plausible mechanism for the GHK component but is uncommon
The Research

Peer-reviewed studies and clinical guidelines - tap any to read the source.

PubMedGHK and DNA: Resetting the Human Genome to Health, Pickart 2014

GHK-Cu Connectivity Map analysis, 4,000+ gene modulation

Read study ↗
PubMedGHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration (PMC4508379)

](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508379/) - comprehensive skin/wound pathway review

Read study ↗
PubMedPentadecapeptide BPC 157 and the central nervous system (PMC9189734)

](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189734/) - BPC-157 mechanism review covering NO/VEGF/angiogenesis pathways

Read study ↗
PubMedBPC-157 enhances Achilles tendon healing in rat (PMC3399574)

](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399574/) - tendon repair model

Read study ↗
PubMedThymosin Beta-4 promotes the migration of human keratinocytes (PMC2933059)

](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933059/) - TB-4 wound healing mechanism

Read study ↗
PubMedThymosin Beta-4 and angiogenesis (PMC2954323)

](https://pubmed.ncbi.nlm.nih.gov/20536615/) - TB-4/TB-500 angiogenesis and tissue repair

Read study ↗
+ 5 more studies & references
From The Community

Aggregated sentiment from public forums & socials - real-world reports, not individual endorsements.

PPeptIQ - BPC-157 + TB-

Injection site sting/burn on push: the most-reported sensation, dose-dependent, attributed to the GHK-Cu copper component. Mitigated by larger BAC volume (3 ml vs 2 ml), warming vial before draw, slow push, injecting into fattier tissue, site rotation. Recurring in PP DMs (multiple customer reports including Lynn 2026, etc.)

Rr/Peptides - GLOW/KLOW

Mild bruising at injection site: common with daily SubQ, low severity

SSeekPeptides - GLOW bl

Cloudy reconstitution: reported as a customer-experience flag rather than a true side effect, the GHK-Cu blue solution can appear cloudy if mixed too fast or cold-shocked, resolves on gentle swirl and warming

RRedFox Peptides - GLOW

Skin tingling at injection area: occasional, transient

RReal Peptides - Wolver

Stinging when injecting on a cold vial: pull vial from fridge 5-10 min before injecting

PPeptIQ - BPC-157 + TB-

Hair regrowth "telogen rush" first 2-4 weeks of hair-focused protocols: occasional anecdotal reports, usually resolves into regrowth phase

Common Questions
SubQ injection (default), topical compounding (community DIY for facial serum use), occasionally injected near target tissue for localized recovery. 1 mg SubQ daily (≈3 IU on a U-100 at 35 mg/ml)
2-4 weeks for skin/recovery feel, 4-8 weeks for visible skin/hair changes
A popular pairing is GLOW + Retatrutide. See the Protocols section, or ask us for a stack built around your goal.
Yes. Every batch is third-party lab tested - request the COA on Telegram and we send it over.
Safety & Contraindications

Hard stops

  • Wilson's disease (copper metabolism disorder, GHK-Cu component delivers copper as a cofactor)
  • Known copper allergy or copper hypersensitivity
  • Active untreated malignancy (GHK-Cu is pro-angiogenic, which is a theoretical concern in tumor environments though no human evidence of cancer promotion exists; the same caution applies to BPC and TB on angiogenic grounds)
  • Pregnancy or lactation (no human safety data for any of the three components in pregnant patients, not "known harmful" but no positive safety signal either)

Caution flags

  • High dietary copper intake (organ meats, oysters, copper supplements) - additive copper load with the GHK component
  • Severe renal impairment (copper excretion goes biliary/renal)
  • Hemochromatosis (iron-copper interaction theoretical)
  • Active skin infections at injection site
  • History of multiple GI surgeries or active IBD flare (BPC-157 is well-tolerated but data here is thin)
  • Long-term continuous use beyond 6 months without zinc supplementation (copper-zinc imbalance)

Stacking conflicts

  • Do NOT mix in syringe with other peptides - copper ion can interact with vitamin C, glutathione, and reducing agents
  • Avoid same-injection-site stacking with vitamin C or glutathione injections (copper-ascorbate, copper-glutathione interactions)
  • Redundant to also run solo BPC-157, TB-500, or GHK-Cu alongside GLOW (you would just be re-buying components already in the blend)
  • Stacking with the Wolverine Blend (BPC + TB only) is redundant for the same reason
  • No documented contraindication with reta, sema, tirz, MOTS-c, CJC+Ipa, NAD+, melanotan, HGH, tesa, testosterone, or any other PP catalog product when administered as separate injections
Is It Right For You?

✓ Good fit

  • skin aging / fine lines / wrinkles
  • hair thinning
  • post-procedural recovery
  • scar reduction
  • wound healing
  • post-reta or post-tirz skin laxity
  • joint/tendon recovery
  • gym recovery
  • anti-aging women 35+
  • customers wanting one pin instead of three
  • longevity-focused customers
  • post-surgical scarring
  • customers running heavy GLP-1 protocols who need recovery layered in

✗ Not a fit

  • Wilson's disease
  • copper allergy
  • pregnancy/lactation
  • customers wanting fat loss or appetite control (wrong category entirely, redirect to GLP-1 line)
  • customers wanting muscle building (redirect to HGH/CJC+Ipa/Tesa)
  • customers who DM expecting visible results in 2 weeks (GLOW is slow on the skin/hair side, real changes show at 4-8 weeks minimum)
  • customers with active inflammation-driven skin conditions like eczema/rosacea (KLOW is the better fit because of the KPV anti-inflammatory layer)

Administration & Storage

Route: SubQ injection (default), topical compounding (community DIY for facial serum use), occasionally injected near target tissue for localized recovery

Injection site: Abdomen or outer thigh, rotate sites. For localized recovery (joint, tendon, scar), researchers sometimes inject SubQ near (not into) the target tissue. For systemic anti-aging or skin focus, rotation between abdominal sites is standard.

Storage: Refrigerated, 28 days standard, up to 4-6 weeks at the outer end. Solution will read pale blue from the GHK-Cu copper ion, this is normal and not contamination. Cloudiness on reconstitution can occur from rapid mixing or cold-shock and resolves on gentle swirling and warming to room temp.

Notes: BAC stings more than other peptides on injection because of the GHK-Cu copper component (recurring customer feedback). Mitigations: reconstitute with 3 ml instead of 2 ml to lower concentration, warm vial in hand 30 seconds before drawing, push slowly, inject into fattier tissue (love handles, lower belly), rotate sites. Customers running long-term GLOW should supplement 15-30 mg zinc daily because copper and zinc compete for absorption, prolonged GHK-Cu can tip the balance. Light-sensitive, store in original vial. Blue color will stain fabric if spilled. Some community users compound GLOW reconstituted solution into a topical hyaluronic acid serum at 0.1-0.5% for facial use, often layered with microneedling once monthly to amplify absorption ~20-fold per published in vitro work on the GHK component.

All products sold for research purposes only. Not for human or animal consumption. Must be 21 or older to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.